Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
RESEARCH TOOLSreports
Holding WST?
Track your performance easily
WST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$309.90 - $415.03
Previous Close$322.98
Volume443.66K
Average Volume (3M)555.69K
Market Cap
$23.53B
Enterprise Value$22.98B
Total Cash (Recent Filing)$853.90M
Total Debt (Recent Filing)$309.00M
Price to Earnings (P/E)42.6
Beta1.25
Next Earnings
Jul 25, 2024EPS Estimate
$1.74Last Dividend Ex-Date
Jul 31, 2024Dividend Yield0.24%
Share Statistics
EPS (TTM)7.58
Shares Outstanding72,843,157
10 Day Avg. Volume705,955
30 Day Avg. Volume555,689
Standard Deviation0.09
R-Squared0.32
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)8.41
Price to Sales (P/S)8.22
Price to Cash Flow (P/CF)25.30
P/FCF Ratio46.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.79
Enterprise Value/Gross Profit20.35
Enterprise Value/Ebitda27.04
Forecast
1Y Price Target
$405.33Price Target Upside26.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
West Pharmaceutical Services News
PremiumCompany Announcements
West Pharmaceutical Adjusts 2024 Guidance Amid Sales Dip
Bulls Say, Bears Say
Bulls Say
Earnings1Q results were above expectations with adjusted EPS significantly ahead, indicating a strong start to the fiscal year.
Financial OutlookManagement maintains a positive outlook for the fiscal year, attributing the steady guidance to early-year conservatism and timing of order dynamics.
Market Leadership And Demand GrowthWest is a market leader in pharmaceutical packaging with elastomers and the largest elastomer supplier for drug makers globally, benefiting from the increasing global demand for medical packaging.
Bears Say
Financial OutlookFY24 guide well-below expectations with organic sales growth of 2-3% and Adj EPS of $7.50-7.75, -14% below estimates.
GuidanceDespite a strong first quarter, the company did not raise the full year sales guide, which could raise concerns about future revenue growth.
Product DemandImprovements in drug efficacy may decrease dosing frequency, potentially reducing the demand for West’s packaging products.
---
Ownership Overview
3.63% Insiders
32.54% Mutual Funds
25.23% Other Institutional Investors
38.60% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
WST FAQ
What was West Pharmaceutical Services, Inc.’s price range in the past 12 months?
West Pharmaceutical Services, Inc. lowest stock price was $309.90 and its highest was $415.03 in the past 12 months.
What is West Pharmaceutical Services, Inc.’s market cap?
Currently, no data Available
When is West Pharmaceutical Services, Inc.’s upcoming earnings report date?
West Pharmaceutical Services, Inc.’s upcoming earnings report date is Jul 25, 2024 which is 124 days ago.
How were West Pharmaceutical Services, Inc.’s earnings last quarter?
West Pharmaceutical Services, Inc. released its earnings results on Apr 25, 2024. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.273 by $0.287.
Is West Pharmaceutical Services, Inc. overvalued?
According to Wall Street analysts West Pharmaceutical Services, Inc.’s price is currently Undervalued.
Does West Pharmaceutical Services, Inc. pay dividends?
West Pharmaceutical Services, Inc. pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.24%. See more information on West Pharmaceutical Services, Inc. dividends here
What is West Pharmaceutical Services, Inc.’s EPS estimate?
West Pharmaceutical Services, Inc.’s EPS estimate is $1.74.
How many shares outstanding does West Pharmaceutical Services, Inc. have?
West Pharmaceutical Services, Inc. has 72,843,155 shares outstanding.
What happened to West Pharmaceutical Services, Inc.’s price movement after its last earnings report?
West Pharmaceutical Services, Inc. reported an EPS of $1.56 in its last earnings report, beating expectations of $1.273. Following the earnings report the stock price went down -4.55%.
Which hedge fund is a major shareholder of West Pharmaceutical Services, Inc.?
Among the largest hedge funds holding West Pharmaceutical Services, Inc.’s share is Intermede Investment Partners Ltd. It holds West Pharmaceutical Services, Inc.’s shares valued at 98M.
---
West Pharmaceutical Services Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$405.33 (26.62% Upside)
$405.33 (26.62% Upside)
Blogger Sentiment
Bullish
WST Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 380.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $595.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.60%
12-Months-Change
Fundamentals
Return on Equity
20.84%
Trailing 12-Months
Asset Growth
-3.26%
Trailing 12-Months
Company Description
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
---
WST Company Deck
---
WST Earnings Call
Q1 2024
0:00 / 0:00
---
WST Revenue Breakdown
81.27% Proprietary Products
18.73% Contract-Manufactured Products
0.00% Intersegment sales elimination
---
WST Stock 12 Month Forecast
Average Price Target
$405.33
▲(26.62% Upside)
Technical Analysis
Best Analysts Covering WST
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+8.32%
assigned a buy rating 5 months ago
Copying David Windley's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +8.32% per trade.
---